Critical Therapeutics
Reports highlight recent developments from Critical Therapeutics
Published in Managed Care Law Weekly, December 24th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Critical Therapeutics.
Report 1: Critical Therapeutics, Inc. (CRTX) announced a new business strategy to focus the company's resources on the commercialization of the twice daily, controlled-release formulation of zileuton (zileuton CR) for the chronic treatment of asthma and on clinical development of the intravenous formulation of zileuton (zileuton IV) for acute asthma.
As part of this initiative, Critical Therapeutics will significantly reduce net cash...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
More Articles from Managed Care Law Weekly
- Accreditation
BlueCross BlueShield of Tennessee awarded URAC Consumer Education and Support Accreditation - Alzheimer Disease
Prana Biotechnology raises $6 million for Phase IIa clinical trial of PBT2 in Alzheimer disease - Awards
Esquire names CNA/NNOC leader Rose Ann DeMoro among "Best and Brightest in America" - Awards
AvMed CEO receives lifetime achievement award - Awards
South Carolina BlueCross wins leadership award for best interactive Web site - Breast Cancer
Certain women may miss out on routine tests that screen for early signs of breast cancer - More from this issue of Managed Care Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
